Metax Life Sciences Limited - Due diligence report

A 360° intelligence report on Metax Life Sciences Limited: trust score, financial health, credit view, compliance, directors, growth and dis…

2000-10-17 Seri Lingampally, Telangana Active Unlisted Active Non-Compliant
Share
View plans Plan
ML Metax Life Sciences Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Metax Life Sciences Limited — 360° Intelligence Report

Generated from MCA filings & public records
41/100
Trust Score
Caution Indicated

Metax Life Sciences Limited is assessed as Caution Indicated with a Trust Score of 41/100. Metax Life Sciences Limited is an active public limited indian non-government company incorporated in 2000, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 13 Jul 2026 from the latest processed filings. Metax Life Sciences Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
41/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
20/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
75/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 1 open (50.00 cr) · 11 satisfied (45.85 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Yes Bank Limited1 48.0 cr
Icici Bank Limited1 48.0 cr
Edelweiss Asset Reconstruction Company Limited2 48.0 cr
State Bank Of India2 48.0 cr
Bank Of Maharashtra1 48.0 cr
Andhra Bank3 48.0 cr
Compliance Score: 20/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: NCLT, BANKS, MCA.
  • Litigation present in 5 court forum(s).
  • 1 auditor resignation(s) filed - latest: PVV & ASSOCIATES on 2024-09-24.
  • 3 active GST registration(s).
Legal cases on record (5)
05

Director Intelligence

Stability score: 75/100
NameDIN / PANDesignationAppointedTenureDIN status
KRISHNA IBRAHIMPATNAM 01234567 Director 01/04/2018 6 yrs Approved
NEEL PRAKASH CHHETRI 01234567 Director 01/04/2018 6 yrs Approved
RISHI RAJENDRA SHAH 01234567 Director 01/04/2018 6 yrs Approved
ASHISH KUMAR 01234567 Director 01/04/2018 6 yrs Approved
Anmol Jain 01234567 Director 01/04/2018 6 yrs Approved
Nihal Navendu Chaubey 01234567 Director 01/04/2018 6 yrs Approved
  • 6 directors on the board.
  • No disqualified or deactivated DINs.
  • 7 director exits in 3 years - high churn.
06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: ASHISH KUMAR (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 45
Growth signals & trust indicators
Operating for 25+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Negative net worth.
5 director exits within 2 years.
Compliance score is weak (20/100).
1 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
5 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence34/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment26/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 50.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view34/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
26 Nov 2025
Charge created
Yes Bank Limited - 50.00 cr
30 Sep 2025
Last AGM held
Annual general meeting
29 Sep 2025
Director ceased
KRISHNA IBRAHIMPATNAM
25 Sep 2025
Charge satisfied
Bank Of Maharashtra
Charge satisfied
Edelweiss Asset Reconstruction Company Limited
24 Sep 2025
Director appointed
Anmol Jain (Director)
Director appointed
Nihal Navendu Chaubey (Director)
22 Sep 2025
Director appointed
RISHI RAJENDRA SHAH (Director)
21 Jun 2025
Director ceased
SHIV CHARAN
31 Mar 2025
Latest balance sheet
Filed with ROC
20 Mar 2025
Director appointed
KRISHNA IBRAHIMPATNAM (Director)
19 Mar 2025
Director ceased
BHARTI AGARWAL
Director ceased
PUSHPA LATA BAI
21 Oct 2024
Charge satisfied
Others
13 Oct 2024
Director ceased
ASHISH KUMAR
10

Key Observations

Auto-generated from the data above
6 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Btm Ventures Private Limited U24100TG2022PTC165997 Shaikpet, Telangana, India
Arbro Formulations Private Limited U24230DL2022PTC395692 Delhi, Delhi, India
Rathi Health Care Private Limited U24232DL2013PTC255618 New Delhi, Delhi, India
Sysmeta Healthineers Private Limited U21002MP2023PTC065406 Gird, Madhya Pradesh, India
Regency Biocare Private Limited U24239HP2013PTC000531 Paonta Sahib, Himachal Pradesh, India
Hyba Private Limited U24110DL2019PTC358434 New Delhi, Delhi, India
Nathan Pharma Private Limited U24290HP2020PTC008227 Baddi, Himachal Pradesh, India
Vanna Extracts Private Limited U24239KA2021PTC147037 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Metax Life Sciences Limited before audits and certifications: compliance score 20/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Metax Life Sciences Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 50/100, margin trends, ownership structure and peer set for Metax Life Sciences Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 41/100, distress signals and MSME payment-delay disclosures - know whether Metax Life Sciences Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (5 case(s) on record), regulatory flags, charge documents trail and director networks for Metax Life Sciences Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Metax Life Sciences Limited an active company?

Metax Life Sciences Limited has MCA status “Active” with a compliance score of 20/100 (Caution Indicated).

Is Metax Life Sciences Limited financially healthy?

Metax Life Sciences Limited has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Metax Life Sciences Limited?

Its overall Trust Score is 41/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Metax Life Sciences Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 6 active director(s) are on record.

Does Metax Life Sciences Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 11 earlier charge(s) stand satisfied.

Is Metax Life Sciences Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 20/100 (Caution Indicated).

Is it risky to lend to Metax Life Sciences Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.